Figure 4From: Impact of therapy escalation on ambulatory care costs among patients with type 2 diabetes in France Additional individual ambulatory care expenditures attributable to T2 DM by treatment phase and resource category in 2010*. *% calculated by treatment line; ex: additional costs in monotherapy = 53% pharmacy + 9% consultations + 5% nursing care + 32% others. Back to article page